Meeder Advisory Services’s Bristol-Myers Squibb BMY Stock Holding History

Meeder Advisory Services's BMY Position: Q1 2026 in Review

Meeder Advisory Services increased its Bristol-Myers Squibb (BMY) stake by 22% in Q1 2026, buying an estimated $313K and bringing the position to 30,119 shares worth $1.83M. The position accounts for 0.08% of the portfolio, ranked #188.

Meeder Advisory Services first reported a position in BMY in Q4 2022 and has held it in 14 quarters since. The position peaked at $2.24M in Q1 2025. 2,518 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

• Meeder Advisory Services held 30,119 shares of Bristol-Myers Squibb worth $1.83M as of Q1 2026.
• Meeder Advisory Services bought 5,361 Bristol-Myers Squibb shares in Q1 2026, an estimated $313K.
• Bristol-Myers Squibb made up 0.08% of Meeder Advisory Services's portfolio in Q1 2026, its #188 holding.
• Meeder Advisory Services first reported a position in Bristol-Myers Squibb in Q4 2022 and has held it in 14 quarters since.
• Meeder Advisory Services's Bristol-Myers Squibb position peaked at $2.24M in Q1 2025.
• 2,518 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Meeder Advisory Services's 13F filing for Q1 2026, filed 7 May 2026.